P552: TREATMENT OUTCOMES IN NEWLY DIAGNOSED, UNTREATED PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

• N. G. Daver,
• S. Iqbal,
• C. Renard,
• R. J. Chan,
• K. Hasegawa,
• H. Hu,
• P. Tse,
• J. Yan,
• M. J. Zoratti,
• F. Xie,
• G. Ramsingh

Affiliations

N. G. Daver

1 The University of Texas MD Anderson Cancer Center, Houston

S. Iqbal

2 Gilead Sciences, Inc., Foster City, United States of America

C. Renard

2 Gilead Sciences, Inc., Foster City, United States of America

R. J. Chan

2 Gilead Sciences, Inc., Foster City, United States of America

K. Hasegawa

2 Gilead Sciences, Inc., Foster City, United States of America

H. Hu

2 Gilead Sciences, Inc., Foster City, United States of America

P. Tse

3 McMaster University, Hamilton, Canada

J. Yan

3 McMaster University, Hamilton, Canada

M. J. Zoratti

3 McMaster University, Hamilton, Canada

F. Xie

3 McMaster University, Hamilton, Canada

G. Ramsingh

2 Gilead Sciences, Inc., Foster City, United States of America